You are here: Industry Insights > pill

News List

Upadacitinib: A Pill for Crohn’s Disease David Orchard-Webb
March 01, 2024
Recently, the U.S. Food and Drug Administration (FDA) approved a groundbreaking oral medication called Upadacitinib (upadacitinib) for adults with moderately to severely active Crohn's disease.
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Drug Development Lin Zhang
December 09, 2020
Artificial Intelligence (AI) is gaining traction across a variety of sectors. AI can be used for a variety of goals and is likely to become a staple in drug development, among other things.
Pharma and Health from Ingredients to Pills: What’s NEW on FDA Easy Labeling ? Lin Zhang
November 23, 2020
Medicine labeling is important and affects individual health on a daily basis, for patients, and the effectiveness of prescriptions for healthcare professionals.
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Pharmacovigilance (PV) Lin Zhang
November 04, 2020
Artificial Intelligence (AI) is a fast emerging technology, dealing with the development and study of intelligent machines and software.
Pharma and Health from Ingredients to Pills: 3D Printing for Personalized Medicine Lin Zhang
June 23, 2020
Personalized medicines are becoming more popular as they enable the use of patient’s unique characteristics which could play a vital role in the treatment of life-threatening diseases.
Pharma and Health from Ingredients to Pills: FDA Drug Recalls 101 Lin Zhang
June 15, 2020
Pharmaceutical drug use in the USA dates back more than a century, and the use of these drugs led to creation of new acts or changes to the existing ones.
Pharma And Health From Ingredients To Pills: Fucoidan Can Alter Gene Expression Lin Zhang
April 13, 2020
In the last few decades，more than 3000 products, derived from marine sources, have been discovered (1). Among the studied Fucoidan has high biocompatibility, lack of toxicity, which has been extensively investigated in pharmaceutical, nutraceutical, biome
Singapore receives its first batch of Pfizer’s Paxlovid pill for COVID-19 treatment FirstWordPharma
February 14, 2022
Singapore has received its first batch of Pfizer's oral COVID-19 treatment Paxlovid, after authorities last week said they had approved the tablet for COVID-19 in adults at risk for severe disease, reported CNA.
EU drug regulator OKs Pfizer COVID pill for high-risk patients ExpressPharma
January 29, 2022
The endorsement by EMA for a conditional approval, if followed as usual by the European Commission, allows EU member states to deploy the drug after the regulator gave guidance for its emergency use late last year.
Pfizer to boost COVID-19 pill production with French deal ExpressPharma
January 18, 2022
The decision is part of Pfizer's strategy to boost global production of the pill, Paxlovid, which was found to be nearly 90 per cent effective in preventing hospitalisations and deaths in patients at high risk of severe illness...